LON:MDCMediclinic International Share Price, Forecast & News

Mediclinic International's stock was trading at GBX 335.70 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MDC shares have decreased by 23.3% and is now trading at GBX 257.40. View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mediclinic International in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Mediclinic International.

Mediclinic International declared a dividend on Thursday, November 14th. Stockholders of record on Thursday, December 5th will be given a dividend of GBX 3.20 per share on Tuesday, December 17th. This represents a dividend yield of 0.85%. The ex-dividend date is Thursday, December 5th. The official announcement can be viewed at this link. View Mediclinic International's dividend history.

4 analysts have issued 1-year price targets for Mediclinic International's shares. Their forecasts range from GBX 260 to GBX 400. On average, they expect Mediclinic International's stock price to reach GBX 325.75 in the next twelve months. This suggests a possible upside of 26.6% from the stock's current price. View analysts' price targets for Mediclinic International.

News articles about MDC stock have trended neutral recently, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Mediclinic International earned a coverage optimism score of 0.2 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Mediclinic International.

Some companies that are related to Mediclinic International include CENTRIC HEALTH (CHH), Healius (HLS), Rhoen Klinikum (RHK), CareTech (CTH), Spire Healthcare Group (SPI), Virtus Health (VRT), Pacific Smiles Group (PSQ), Georgia Healthcare Group (GHG), Sanara MedTech (SMTI), Assure (IOM), Totally (TLY), Konekt (KKT), Brain Resource (BRC), Nobilis Health (HLTH) and Wellness and Beauty (WNB). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Mediclinic International investors own include Intu Properties (INTU), Capital & Counties Properties PLC (CAPC), RDI Reit (RDI), British American Tobacco Plc Ads (BATS), Central Asia Metals (CAML), DRDGOLD (DRD), UK Oil & Gas (UKOG), Spire Healthcare Group (SPI), Premier Oil (PMO) and Ferrexpo (FXPO).

Mediclinic International trades on the London Stock Exchange (LON) under the ticker symbol "MDC."

Shares of MDC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of MDC stock can currently be purchased for approximately GBX 257.40.

Mediclinic International has a market capitalization of £1.90 billion and generates £3.08 billion in revenue each year. Mediclinic International employs 33,629 workers across the globe.

The official website for Mediclinic International is www.mediclinic.com.

Mediclinic International's mailing address is 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom. The company can be reached via phone at +44-20-79549600.